Appendix_2_GLeblanc – Supplemental material for Incidence and impact of withdrawal
of life-sustaining therapies in clinical trials of severe traumatic brain injury: A
systematic review
Guillaume Leblanc
Amélie Boutin
Michèle Shemilt
François Lauzier
Lynne Moore
Véronique Potvin
Ryan Zarychanski
Patrick Archambault
François Lamontagne
Caroline Léger
Alexis F Turgeon
10.25384/SAGE.6820730.v1
https://sage.figshare.com/articles/journal_contribution/Appendix_2_GLeblanc_Supplemental_material_for_Incidence_and_impact_of_withdrawal__of_life-sustaining_therapies_in_clinical_trials_of_severe_traumatic_brain_injury_A__systematic_review/6820730
<p>Supplemental material, Appendix_2_GLeblanc for Incidence and impact of withdrawal of
life-sustaining therapies in clinical trials of severe traumatic brain injury: A
systematic review by Guillaume Leblanc, Amélie Boutin, Michèle Shemilt, François Lauzier,
Lynne Moore, Véronique Potvin, Ryan Zarychanski, Patrick Archambault, François Lamontagne,
Caroline Léger and Alexis F Turgeon in Clinical Trials</p>
2018-06-04 12:00:00
Brain injury
clinical trial
life-sustaining therapy
end-of-life